The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.EBI
Universitat De Barcelona
Binding and Proton Blockage by Amantadine Variants of the Influenza M2EBI
National and Kapodistrian University of Athens
Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.EBI
The University of Arizona
Synthesis and structure-activity relationship study of arylsulfonamides as novel potent H5N1 inhibitors.EBI
Wuhan University
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants.EBI
National and Kapodistrian University of Athens
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.EBI
Csir-National Chemical Laboratory
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.EBI
Universitat De Barcelona